8
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of Low Dose Prednisone Plus Aspirin in Preventing Spontaneous Abortions and/or Fetal Deaths Due to Antiphospholipid Antibodies: Results of a Pilot Study

, , , , , , , & show all
Pages 123-125 | Received 20 May 1996, Accepted 20 May 1996, Published online: 07 Jul 2009

References

  • Harris E. N. Antiphospholipid antibodies. Br. J. Haematol 1990; 74: 1–9
  • Feinstein D. I. Lupus anticoagulant, thrombosis and fetal loss. N. Engl. J. Med 1985; 313: 1351
  • Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus‐anticoagulant. Lancet 1983; 1: 1361–1363
  • Branch D. W., Silver R. M., Blackwell J. L., Scott J. R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an updated of the Utah experience. Obstet. Gynecol 1992; 80: 414–420
  • Cowchock F. S., Reece E. A., Balaban D., Branch W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low‐dose heparin treatment. Am. J Obstet. Gynecol 1992; 166: 1318–1323
  • Silver R. K., MacGregor S. N., Sholl J. S., Hobart J. M., Neerhof M. G., Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody‐positive obstetric patients. Am. J Obstet. Gynecol 1993; 169: 1411–1417

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.